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Non-specific chronic low back pain (nsCLBP) is a multifactorial condition of unknown 
etiology and pathogenesis. Physical and genetic factors may influence the predispo-
sition of individuals to CLBP, which in many instances share a musculoskeletal origin. 
A reduced pain level in low back pain patients that participate in exercise therapy high-
lights that disuse-related muscle deconditioning may predispose individuals to nsCLBP. 
In this context, musculoskeletal pain may be the consequence of capillary rarefaction 
in inactive muscle as this would lower local tissue drainage and washing out of toxic 
waste. Muscle activity is translated into an angio-adaptative process, which implicates 
angiogenic-gene expression and individual response differences due to heritable 
modifications of such genes (gene polymorphisms). The pathophysiologic mechanism 
underlying nsCLBP is still largely unaddressed. We hypothesize that capillary rarefaction 
due to a deconditioning of dorsal muscle groups exacerbates nsCLBP by increasing 
noxious sensation, reducing muscle strength and fatigue resistance by initiating a down-
ward spiral of local deconditioning of back muscles which diminishes their load-bearing 
capacity. We address the idea that specific factors such as angiotensin-converting 
enzyme and Tenascin-C might play an important role in altering susceptibility to nsCLBP 
via their effects on microvascular perfusion and vascular remodeling of skeletal muscle, 
inflammation, and pain sensation. The genetic profile may help to explain the individual 
predisposition to nsCLBP, thus identifying subgroups of patients, which could benefit 
from ad hoc treatment types. Future therapeutic approaches aimed at relieving the pain 
associated with nsCLBP should be based on the verification of mechanistic processes 
of activity-induced angio-adaptation and muscle-perfusion.
Keywords: non-specific chronic low back pain, muscle perfusion, gene polymorphisms, pain sensation, 
therapeutics
OvervieW OF tHe cLiNicAL MANiFestAtiON
Low back pain (LBP) is the most common cause for years lived with a disability (1) with 60–80% of 
the adult population reporting LBP for some time along their lives (2). Problematic is the fact that 
only 5–15% of all LBP cases can be associated with a specific cause. The majority of patients with 
LBP present non-specific form, in which no common anatomical origin of the pathology can be 
identified and matched to the patient’s complaints (3). Non-specific LBP accounts for 70–90% of all 
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LBP cases (3–5). Most LBP cases recover within days or weeks 
without further complications after first signs of pain manifest 
(6). However, a minority of about 10% does not recover and 
develop chronic LBP (CLBP), identified as a condition lasting 
longer than three months (3, 7). Although CLBP is recognized to 
present a multifactorial origin, the occurring pain in this group of 
non-specific chronic low back pain (nsCLBP) is often associated 
with musculoskeletal disorders (8).
MUscLe DisUse AND DecONDitiONiNG 
iN nscLBP
The muscular system is of pivotal importance for the stabil-
ity and movement of the spine (9). Inappropriate use of local 
musculoskeletal system blunts the impact of physiological cues 
which are required to maintain the functional capacity of muscle 
through instructing homeostatic processes and adaptation (10). 
As a consequence, the musculoskeletal system is deconditioned 
and the capacity of stabilize posture and move is compromised 
(11, 12). On one hand, muscle deconditioning, due to a congeni-
tal or acquired lowering of muscle activity can be seen as a cause 
of nsCLBP. This may cause constant overloading of the lumbar 
muscles and subsequent increase in muscular fatigue (13, 14) 
which ultimately may lead to nsCLBP. On the other hand, muscle 
deconditioning can be regarded as a consequence of CLBP due 
to a vicious cycle consisting of an initial injury, which may lead 
to pain and subsequent avoidance behavior regarding physical 
activities due to the fear of re-injury (15). Such vicious cycle 
may lead to muscle deconditioning, leaving the patient unable 
to sustain “normal” everyday loading (16–18). Whether muscle 
deconditioning represents a possible cause or, instead, conse-
quence of nsCLBP, is still a point of debate (17, 19).
In a recent review, Steele et  al. (15) have pointed out that 
“deconditioning” (i.e., defined by the authors as a “decrease in 
function”) may not be only caused by “disuse” [defined by Verbunt 
et al. as a decrease in physical activity levels (17)]. In LBP, trunk 
muscles concomitantly undergo a specific acute-to-chronic phase 
remodeling which usually leads to a reduced cross-sectional 
area (CSA) of involved muscles (20). This phenomenon is well 
understood to reflect a specific local response of muscle tissue 
to the reduced impact of use-related metabolic and mechanical 
cues, or muscle disuse (21).
Muscular disuse is defined as the response to decreased usage, 
leading to a reductive remodeling of the tissue (22), accompanied 
with a shift from slow to fast myosin isoforms muscle phenotype 
(23), markedly decreased force output and fatigue resistance, 
lower neural activation, reduced metabolic supply due to capil-
lary rarefaction, and a diminished local oxidative capacity (24). 
This physiological definition of disuse distinguished from the 
one describing disuse as a “general lack or reduction of physi-
cal activity level.” Lower physical activity levels can indeed be 
associated with local muscle disuse and deconditioning (25), 
but some authors have found inconclusive relationships between 
physical activity and CLBP (17), as whole body activity levels 
seem not to differ between healthy controls and CLBP patients 
(26). However, in the formed instances physical activity was 
assessed by accelerometer and average daily metabolic rate to 
resting metabolic rate ratio (26). As no information on local-
ized (i.e., trunk) muscle activation or energy expenditure was 
provided, the presence of concomitant local muscle disuse can-
not be excluded. Thus, muscle disuse may still be regarded as a 
cause of nsCLBP pathology. To date, as it is unsolved whether 
muscle deconditioning is cause or consequence of disuse; there 
is an urge for longitudinal investigations with clearly defined 
and standardized measures for conditioning levels (strength and 
endurance) and strict control of influencing factors (17).
iNDicAtOrs OF MUscLe 
DecONDitiONiNG iN nscLBP
Morphological indicators of muscle deconditioning are provided 
by imaging and histochemical studies of lumbar musculature. 
During deconditioning, skeletal muscles go through remodeling 
processes that lead subsequently to a significant loss in mass (15). 
After prolonged physical inactivity, paraspinal muscles undergo 
atrophic processes (27, 28): morphometric estimates based on 
magnetic resonance imaging (MRI) presented a decrease of CSA 
in paraspinal muscle, especially the multifidus (20, 29). Similar 
patterns of atrophy have been demonstrated using ultrasound 
imaging (30, 31) and computed tomography (CT) (32–34). 
Although the significance of paraspinal muscle atrophy role in 
predicting long term of LBP has been challenged (35, 36), there 
is evidence for a time-dependent selective ipsilateral atrophy 
of distinct muscle groups specific for the symptomatic side 
(37, 38). This remodeling process varies between the acute and 
CLBP phase, which affects psoas major/erector spinae and mul-
tifidus/erector spinae, respectively (37). Goubert et al. stated in a 
recent review that, in nsCLBP patients, multifidus and paraspinal 
muscle, but not erector spinae, present the most significant 
reduction in CSA (39). Nonetheless, transverse relaxation time 
(T2) MRI analyses revealed abnormalities and asymmetries 
of low back muscles in patients with acute LBP (40) and such 
alterations in MRI-derived T2 can be associated with muscle 
(i.e., multifidus) disuse/altered use of multifidus muscle even 
after cessation of LBP (41).
Magnetic resonance imaging data have been used in order to 
measure an alteration of imaging signal intensity, which can be 
regarded as an index of muscle quality and increase in fat content, 
which in turn has been found associated with LBP (42, 43).
In addition, histological studies have pointed out changes in 
the fiber type distribution of back muscles, presenting a shift 
(in paraspinal muscle) toward the fast-fatiguable type IIX fibers 
(14, 44, 45).
Functional indicators of muscle deconditioning in patients 
with nsCLBP are represented by weakness of trunk muscles, 
measured either by isometric or isokinetic contractions (46) and 
reduced endurance of lumbar extensor muscles (47). There is 
evidence that individuals with CLBP have a delayed activation of 
back muscle activity when performing prone hip extension (48). 
Lower activation patterns (EMG) of multifidus and other lumbar 
muscles have been showed during sitting in non-specific CLBP 
patients compared with healthy controls (49).
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eXercise-trAiNiNG reGiMes  
iN nscLBP: tHe stOrY sO FAr
It is well established that muscle strength and endurance are 
compromised in consequence of muscle atrophy and decondi-
tioning (50–53). Therapeutic interventions should be identified 
and applied to mitigate the atrophic process. Previous training 
interventions were performed in patients with CLBP, in which 
lumbar multifidus muscle CSA was found to increase after 
10 weeks of stabilization training combined with dynamic-static 
resistance training (32).
However, there are controversial opinions concerning the 
rela tionship between improving trunk muscle performance (i.e., 
strength/endurance) and relief of painful symptoms and disabil-
ity (54). We identify that this criticism is related to the lack of 
a specific exercise treatment to halt LBP and evidence for casual 
relationship between changes in strength or CSA and pain and dis-
ability level, respectively (55). The note of a relationship between 
pain and muscle’s force producing capacity is provided by the fact 
that a failure of paraspinal muscles in protecting passive spinal and 
pelvic structures from excessive loading in daily living maneuvers 
or sport activities may result in damage to these pain-sensitive 
structures thus elevating noxious influences. For this reason, spe-
cific forms of resistance exercise are often recommended for back 
pain patients. The conditioning of musculature by progressive 
resistance exercise improves muscle hypertrophy, strength/endur-
ance performance, and cardiovascular capacity (56). In addition, 
therapeutic training that improves both of the former parameters 
was found to relieve symptoms of CLBP and disability (54, 57) 
related to musculoskeletal disorders. There is also evidence for a 
combination of electrical stimulation or ultrasound therapy and 
exercises in increasing quality of life by improving pain, muscle 
strength/endurance and spine mobility (58).
MUscLe PerFUsiON AND nscLBP
In the late 1700s, a Scottish surgeon (John Hunter) observed 
that “blood goes to where it is needed” (59). Along this original 
line of observations it is now understood that the primary effect 
of mechanical-stimuli such as repeated muscle contractions 
will produce a significant increase in cardiac output followed 
by an increase in blood volume. Thus, the vast majority of the 
increased metabolic and mechanical demand is allocated to the 
contracting skeletal muscle and adequate muscle perfusion is 
crucial (60).
Muscle tissue is dependent on sufficient blood perfusion in 
terms of maintaining oxygen- and nutrient levels according to 
its demands (61). Insufficiency of both, oxygen- and nutrient 
levels, as well as insufficient removal of toxic products of the mus-
cle metabolism, causes pain, and deteriorate physiological func-
tioning (62). Thus, capillary regression or rarefaction, caused by 
phy sical deconditioning, chronic vasoconstriction, maladaptive 
alterations/diseases of the microvascular bed, or endothelial dys-
function in muscle tissue (63–65), may lead to muscle ischemia 
in consequence of an insufficient blood flow and decreased 
oxygen extraction within the muscle tissue due to an associated 
reduction in aerobic capacity of muscle fibers (66).
Previous literature highlighted the evidence for a potential 
connection between impaired perfusion (i.e., atherosclerosis and 
stenosis of lumbar arteries) and CLBP (67, 68). Other studies 
showed that an insufficient lower limb perfusion may induce 
a similar symptom as neuropathic pain (69, 70). Interestingly, 
prolonged retraction of the paraspinal muscle as induced during 
spinal surgery may reduce muscle perfusion and trigger back pain 
and disability (71). Paraspinal compartment syndrome is asso-
ciated with reduced tissue perfusion that causes ischemic pain 
(72) as well as disk degeneration (67).
Taken together, these data point to insufficient blood supply, 
with evidence for hypoxic or ischemic conditions within the 
lumbar compartment, which may affect the metabolism of verte-
bral bone, nerve roots, intervertebral disks, and lumbar muscles. 
Interestingly, some study suggests that CLBP patients present an 
impairment to deliver oxygen in erector spinae muscle, which can 
be partly restored during exercise (73–75).
MUscULAr ANGiO-ADAPtAtiON  
AND cLBP
Aberrant governance of back muscle strength and endurance 
through use dependent vascular perfusion may represent a 
critical event in the etiology and progression of CLBP. In this 
context, a critical lack of dynamic back muscle work is a pos-
sible causal factor leading to muscle deconditioning through 
rarefaction of capillaries and reduced aerobic capacity (76). 
Regression of muscle capillaries is a common consequence in 
physical deconditioning (i.e., hind limb unloading) and chronic 
diseases such as diabetes, obesity, chronic heart failure, or chronic 
obstructive pulmonary disease (76, 77). The consequent micro-
circulatory dysfunction exacerbates the compounds underlying 
the pathology through further inflammation and impaired deli-
very of oxygen and substrate to tissues (78, 79). Although the 
pathophysiologic mechanisms remain unclear, it is known that 
capillary supply supports the homeostatic processes in muscle 
tissue: a qualitative and quantitative improvement in muscle 
perfusion, following arteriolar vasodilatation and growth of 
the capillary tree, enhances muscle metabolic capacity to aug-
ment resistance to fatigue (80, 81). Moreover, a better perfusion 
could explain analgesia produced by washing out of toxic wastes 
and reducing muscle and joint stiffness (82).
In normal adult skeletal muscle, the genesis and turnover of 
capillaries and muscle fibers are inter-related (80, 83, 84). Being 
skeletal muscle a plastic tissue, under repeated mechanical stim-
uli, angiogenesis is requested to compensate perfusion distance 
between capillaries and muscle fibers. Several potential stimuli 
have been postulated to underlie angiogenesis in exercised mus-
cle. An increase in blood flow within a vessel causes increases in 
shear stress and lowered oxygenation, which is a major stimulus 
in the remodeling and capillary growth (85). In fact, abluminal 
mechanical stress (i.e., stretch) of muscle tissue with static or 
repeated cycles of muscle contraction represents the physiologi-
cal growth stimulus for the embedded capillaries which is equally 
effective as liminal sheer stress to induce growth of the capillary 
endothelium through the sprouting of existing blood vessels 
(84, 86). In this process, vasoactive factors initiate and control 
FiGUre 1 | Peripheral blood perfusion in relationship with angiogenic factors (ACE and TNC) and chronic muscle pain. Interactions between muscle deconditioning/
conditioning responses and the Angio-adaptation process. Arrows (+) indicate promotion and Arrows (−) indicate reduction. Documented interactions are fully 
colored in green and red, while dotted lines represent our postulated interactions in this pathway. ACE I, angiotensin-converting enzyme insertion; ACE D, 
angiotensin-converting enzyme deletion; TNC, Tenascin-C (rs2104772); A, adenine; T, thymine. The TNC-T and ACE-D polymorphism may result in a less-efficient 
vascular remodeling-perfusion and exacerbation of muscle pain by an increase of nitric oxide (NO) and acidosis-related process.
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the remodeling of the basement membrane that surrounds the 
capillary endothelium by regulating the proliferative activity 
and motility of endothelial cells (ECs). Capillary remodeling 
encompasses changes in the connections between the ECs and 
the extracellular matrix (ECM) proteins through the activation 
and enhanced synthesis of adhesive and cytoskeletal proteins 
and extracellular proteases. Molecular control of the angiogenic 
process is then orchestrated by the interplay between the activa-
tion of ECs and turnover of the ECM. There is growing evidence 
suggesting that matrix-derived factors play a critical role in regu-
lating muscle angiogenesis (87). The endothelium and myogenic 
control collaborate in vascular adaptation in response to several 
stimuli during vasodilatation/vasoconstriction responses (88).
tHe “MUscLe PerFUsiON” AND “PAiN” 
HYPOtHesis
On the basis of the aforementioned evidence, we develop the 
idea that individuals with nsCLBP might present an attenuation 
of muscle-perfusion, due to muscle deconditioning and concomi-
tant disuse. In this scenario, an altered perfusion and rarefaction 
of capillaries may be the result of a complex interplay between 
genetic predisposition and environmental cues (such as muscle 
deconditioning).
Several studies have investigated a possible linkage between 
the musculoskeletal system and genetic polymorphisms affect-
ing pro- and anti-angiogenic factors, in particular those being 
associated with the remodeling of the ECM and the proliferation 
of ECs (89). Perfusion-related angio-adaptation may implicate 
the regulation of muscle’s vascular bed by two potentially angio-
genic modulators, angiotensin-converting enzyme (ACE) and 
Tenascin-C (TNC).
In a recent investigation, we have illustrated how ACE and 
(TNC) cooperate during muscular and vascular-remodeling (90). 
In cultured smooth muscle cells, TNC expression is induced by 
the vasoconstrictor peptide angiotensin II and is found increased 
in vascular structures in patients with hypertension (91–93). 
TNC is highly expressed in migrating ECs and branching sites of 
blood vessels (91, 94, 95). Suspicion is high that vasoconstriction 
and remodeling of resistance vessels are somehow connected 
and that, while TNC mediates the effect of angiotensin II, ACE in 
turn catalyzes the conversion of angiotensin I to angiotensin II.
5Valdivieso et al. Muscle Perfusion and CLBP
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We then propose that the aforementioned gene polymor-
phisms, being associated with muscular hypoperfusion due 
to an enhanced vasoconstriction, may importantly modify the 
angio-adaptation process. Consequently, we advocate investigat-
ing the association between single-nucleotide polymorphisms 
(SNPs) within the ACE and TNC genes together with changes 
in morphologic and functional characteristics of skeletal muscle, 
and clinical outcomes (pain, disability) in patients with nsCLBP 
in response to therapeutic exercise training (Figure  1, for a 
synopsis). The proposed mechanism may then operate in two 
distinct ways: on one hand, vasoconstriction will be regulated 
by ACE-I/D polymorphism, with the presence (I-allele) or the 
absence (D-allele) in intron 16 of the ACE gene. Presence of 
the I-allele may then lower ACE activity in skeletal muscle and 
the production of Angiotensin II (96, 97). On the other hand, 
remodeling will also be associated with polymorphism in the 
TNC gene (98). In particular, rs2104772 polymorphism describes 
a thymidine (T)-to-adenosine (A) exchange at nucleotide posi-
tion 44513 in the TNC gene that instructs the substitution of 
leucine by isoleucine at amino acid position 1677 and it may alter 
the molecular elasticity of the TNC Fn-III-D domain (99, 100). 
Speculatively, via this molecular effect, the TNC T-allele coop-
erates with the ACE D/D modulated vasoconstriction to blunt 
vascular remodeling and increased perfusion in back muscles 
after exercise training compared with other polymorphisms. 
There is evidence for a direct modulatory connection bet ween 
the ACE enzyme and pain sensation through modification 
of the balance between the vasoconstrictive angiotensin peptide 
and pain-modulatory and vasodilatatory peptides of the kinin 
family, bradykinin and substance P (101, 102). For instance, ACE 
degrades substance P into its inactive form and ACE-regulated 
vasoconstriction exacerbates muscle pain by an acidosis-related 
process (103). There is in fact mounting evidence that acidosis 
could activate muscle pain sensation mediated by activation of 
acid-sensing ion channels (104) and there is mounting evidence 
that proton-sensing receptors are involved in the Transition from 
Acute to Chronic Pain (105).
Intriguingly, substance P signaling was recently pointed out to 
exert an anti-nociceptive role through modulation of activation 
potential threshold in certain muscle nociceptors as well (103). 
While the underlying patho-physiological process remains to be 
disentangled, ACE-mediated inhibition of substance P emerges as 
a potentially important factor affecting pain sensation in nsCLBP.
However, there is evidence that repeated nociceptive stimuli 
can alter peripheral and/or central sensitization, resulting in the 
chronicity of pain with both nociceptive and neuropathic pain 
components (106). Combination pharmacotherapy is often nec-
essary in patients with CLBP, in order to manage both nociceptive 
and neuropathic pain (107).
It is noteworthy to highlight that the first line therapy in CLBP 
recommend the use of vasoactive drugs. Acetaminophen (par-
acetamol) and non-steroidal anti-inflammatory drugs “NSAIDs” 
or opioids are common drugs and have widespread use for 
acute and chronic musculoskeletal disorders. The advantage is 
a peripheral effect in alleviating ischemic pain by independent 
mechanisms of vasodilation that increase blood flow in nerve 
and in muscle tissue.
cLiNicAL reLevANce AND FUtUre 
DirectiON
The postulated connection of CLBP and lower muscle perfusion 
provides a conceptual framework to develop a treatment that 
tackles the pain generating mechanism with a personalized 
approach.
Toward this end, studies should first investigate the asso-
ciation between CLBP and polymorphisms for use-dependent 
angiogenic factor expression that may predict the CLBP pathol-
ogy. Successively, investigations should gain insights into such 
polymorphisms and their significant role in vascular muscle 
remodeling in response to exercise training. From here, potential 
tailored exercise programs should be identified, aimed at improv-
ing strength and fatigue resistance of the back muscles in order 
to likely protect or minimize the effects of injurious events and 
reduce sensitivity to pain.
AUtHOr cONtriBUtiONs
PV conceived the manuscript. PV, MFr, and MFl contributed to 
the writing of the manuscript. PV, MFr, CG, and MFl edited and 
produced the final version of the manuscript.
reFereNces
1. GBD 2013 DALYs and HALE Collaborators, Murray CJ, Barber RM, 
Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, et al. Global, regional, and 
national disability-adjusted life years (DALYs) for 306 diseases and injuries 
and healthy life expectancy (HALE) for 188 countries, 1990–2013: quanti-
fying the epidemiological transition. Lancet (2015) 386(10009):2145–91. 
doi:10.1016/S0140-6736(15)61340-X 
2. Conway R, Behennah J, Fisher J, Osborne N, Steele J. Associations between 
trunk extension endurance and isolated lumbar extension strength in both 
asymptomatic participants and those with chronic low back pain. Healthcare 
(Basel) (2016) 4(3):E70. doi:10.3390/healthcare4030070 
3. Deyo RA, Weinstein JN. Low back pain. N Engl J Med (2001) 344(5):363–70. 
doi:10.1056/NEJM200102013440508 
4. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet 
(2017) 389(10070):736–47. doi:10.1016/S0140-6736(16)30970-9 
5. Balague F, Mannion AF, Pellise F, Cedraschi C. Non-specific low back pain. 
Lancet (2012) 379(9814):482–91. doi:10.1016/S0140-6736(11)60610-7 
6. Coste J, Schiano PJ, Leparc JM, Paolaggi JB. Clinical and psychological 
classification of non-specific low-back pain. A new study in primary care 
practice. Rev Epidemiol Sante Publique (1995) 43(2):127–38. 
7. Andersson GB. Epidemiological features of chronic low-back pain. Lancet 
(1999) 354(9178):581–5. doi:10.1016/S0140-6736(99)01312-4 
8. Musculoskeletal Disorders and the Workplace: Low Back and Upper Extremities. 
Washington, DC: National Academies Press (2001). Avaliable from https://
www.ncbi.nlm.nih.gov/books/NBK222440/
9. Cholewicki J, McGill SM. Mechanical stability of the in vivo lumbar spine: 
implications for injury and chronic low back pain. Clin Biomech (Bristol, 
Avon) (1996) 11(1):1–15. doi:10.1016/0268-0033(95)00035-6 
10. Bortz WM II. The disuse syndrome. West J Med (1984) 141(5):691–4. 
11. Mayer TG, Barnes D, Nichols G, Kishino ND, Coval K, Piel B, et  al. 
Progressive isoinertial lifting evaluation. II. A comparison with isokinetic 
6Valdivieso et al. Muscle Perfusion and CLBP
Frontiers in Medicine | www.frontiersin.org March 2018 | Volume 5 | Article 77
lifting in a disabled chronic low-back pain industrial population. 
Spine (Phila Pa 1976) (1988) 13(9):998–1002. doi:10.1097/00007632- 
198809000-00006 
12. Bousema EJ, Verbunt JA, Seelen HA, Vlaeyen JW, Knottnerus JA. Disuse and 
physical deconditioning in the first year after the onset of back pain. Pain 
(2007) 130(3):279–86. doi:10.1016/j.pain.2007.03.024 
13. Kravitz E, Moore ME, Glaros A. Paralumbar muscle activity in chronic low 
back pain. Arch Phys Med Rehabil (1981) 62(4):172–6. 
14. Mannion AF, Kaser L, Weber E, Rhyner A, Dvorak J, Muntener M. Influence 
of age and duration of symptoms on fibre type distribution and size of 
the back muscles in chronic low back pain patients. Eur Spine J (2000) 
9(4):273–81. doi:10.1007/s005860000189 
15. Steele J, Bruce-Low S, Smith D. A reappraisal of the deconditioning hypoth-
esis in low back pain: review of evidence from a triumvirate of research 
methods on specific lumbar extensor deconditioning. Curr Med Res Opin 
(2014) 30(5):865–911. doi:10.1185/03007995.2013.875465 
16. Verbunt JA, Seelen HA, Vlaeyen JW, van de Heijden GJ, Heuts PH, Pons K, 
et al. Disuse and deconditioning in chronic low back pain: concepts and hypoth-
eses on contributing mechanisms. Eur J Pain (2003) 7(1):9–21. doi:10.1016/ 
S1090-3801(02)00071-X 
17. Verbunt JA, Smeets RJ, Wittink HM. Cause or effect? Deconditioning 
and chronic low back pain. Pain (2010) 149(3):428–30. doi:10.1016/j.
pain.2010.01.020 
18. Smeets RJ, Vlaeyen JW, Kester AD, Knottnerus JA. Reduction of pain cata-
strophizing mediates the outcome of both physical and cognitive-behavioral 
treatment in chronic low back pain. J Pain (2006) 7(4):261–71. doi:10.1016/j.
jpain.2005.10.011 
19. Brumagne S, Cordo P, Lysens R, Verschueren S, Swinnen S. The role of 
paraspinal muscle spindles in lumbosacral position sense in individuals 
with and without low back pain. Spine (Phila Pa 1976) (2000) 25(8):989–94. 
doi:10.1097/00007632-200004150-00015 
20. Fortin M, Macedo LG. Multifidus and paraspinal muscle group cross- 
sectional areas of patients with low back pain and control patients: a sys-
tematic review with a focus on blinding. Phys Ther (2013) 93(7):873–88. 
doi:10.2522/ptj.20120457 
21. Thomason DB, Booth FW. Atrophy of the soleus muscle by hindlimb 
unweighting. J Appl Physiol (1985) (1990) 68(1):1–12. doi:10.1152/
jappl.1990.68.1.1 
22. Stein TP, Wade CE. Metabolic consequences of muscle disuse atrophy. J Nutr 
(2005) 135(7):1824S–8S. doi:10.1093/jn/135.7.1824S 
23. Harridge SD. Plasticity of human skeletal muscle: gene expression to 
in vivo function. Exp Physiol (2007) 92(5):783–97. doi:10.1113/expphysiol. 
2006.036525 
24. Bogdanis GC. Effects of physical activity and inactivity on muscle fatigue. 
Front Physiol (2012) 3:142. doi:10.3389/fphys.2012.00142 
25. Bell KE, von Allmen MT, Devries MC, Phillips SM. Muscle disuse as a pivotal 
problem in sarcopenia-related muscle loss and dysfunction. J Frailty Aging 
(2016) 5(1):33–41. doi:10.14283/jfa.2016.78 
26. Verbunt JA, Westerterp KR, van der Heijden GJ, Seelen HA, Vlaeyen JW, 
Knottnerus JA. Physical activity in daily life in patients with chronic low 
back pain. Arch Phys Med Rehabil (2001) 82(6):726–30. doi:10.1053/
apmr.2001.23182 
27. Kader DF, Wardlaw D, Smith FW. Correlation between the MRI changes in 
the lumbar multifidus muscles and leg pain. Clin Radiol (2000) 55(2):145–9. 
doi:10.1053/crad.1999.0340 
28. Kamaz M, Kiresi D, Oguz H, Emlik D, Levendoglu F. CT measurement of 
trunk muscle areas in patients with chronic low back pain. Diagn Interv 
Radiol (2007) 13(3):144–8. 
29. Barker KL, Shamley DR, Jackson D. Changes in the cross-sectional area 
of multifidus and psoas in patients with unilateral back pain: the relation-
ship to pain and disability. Spine (Phila Pa 1976) (2004) 29(22):E515–9. 
doi:10.1097/01.brs.0000144405.11661.eb 
30. Hides J, Gilmore C, Stanton W, Bohlscheid E. Multifidus size and symmetry 
among chronic LBP and healthy asymptomatic subjects. Man Ther (2008) 
13(1):43–9. doi:10.1016/j.math.2006.07.017 
31. Wallwork TL, Stanton WR, Freke M, Hides JA. The effect of chronic low 
back pain on size and contraction of the lumbar multifidus muscle. Man Ther 
(2009) 14(5):496–500. doi:10.1016/j.math.2008.09.006 
32. Danneels LA, Cools AM, Vanderstraeten GG, Cambier DC, Witvrouw EE, 
Bourgois J, et  al. The effects of three different training modalities on the 
cross-sectional area of the paravertebral muscles. Scand J Med Sci Sports 
(2001) 11(6):335–41. doi:10.1034/j.1600-0838.2001.110604.x 
33. Danneels LA, Vanderstraeten GG, Cambier DC, Witvrouw EE, Bourgois J, 
Dankaerts W, et al. Effects of three different training modalities on the cross 
sectional area of the lumbar multifidus muscle in patients with chronic low 
back pain. Br J Sports Med (2001) 35(3):186–91. doi:10.1136/bjsm.35.3.186 
34. Danneels LA, Vanderstraeten GG, Cambier DC, Witvrouw EE, De Cuyper HJ. 
CT imaging of trunk muscles in chronic low back pain patients and healthy 
control subjects. Eur Spine J (2000) 9(4):266–72. doi:10.1007/s005860000190 
35. Fortin M, Gibbons LE, Videman T, Battie MC. Do variations in paraspinal 
muscle morphology and composition predict low back pain in men? Scand 
J Med Sci Sports (2015) 25(6):880–7. doi:10.1111/sms.12301 
36. Kalichman L, Carmeli E, Been E. The association between imaging para-
meters of the paraspinal muscles, spinal degeneration, and low back pain. 
Biomed Res Int (2017) 2017:2562957. doi:10.1155/2017/2562957 
37. Wan Q, Lin C, Li X, Zeng W, Ma C. MRI assessment of paraspinal muscles 
in patients with acute and chronic unilateral low back pain. Br J Radiol (2015) 
88(1053):20140546. doi:10.1259/bjr.20140546 
38. Huang Q, Zhang Y, Li D, Yang D, Huo M, Maruyama H. The evaluation of 
chronic low back pain by determining the ratio of the lumbar multifidus 
muscle cross-sectional areas of the unaffected and affected sides. J Phys Ther 
Sci (2014) 26(10):1613–4. doi:10.1589/jpts.26.1613 
39. Goubert D, Oosterwijck JV, Meeus M, Danneels L. Structural changes of 
lumbar muscles in non-specific low back pain: a systematic review. Pain 
Physician (2016) 19(7):E985–1000. 
40. Clark BC, Walkowski S, Conatser RR, Eland DC, Howell JN. Muscle 
functional magnetic resonance imaging and acute low back pain: a pilot 
study to characterize lumbar muscle activity asymmetries and examine the 
effects of osteopathic manipulative treatment. Osteopath Med Prim Care 
(2009) 3:7. doi:10.1186/1750-4732-3-7 
41. D’Hooge R, Cagnie B, Crombez G, Vanderstraeten G, Achten E, Danneels L. 
Lumbar muscle dysfunction during remission of unilateral recurrent non-
specific low-back pain: evaluation with muscle functional MRI. Clin J Pain 
(2013) 29(3):187–94. doi:10.1097/AJP.0b013e31824ed170 
42. Teichtahl AJ, Urquhart DM, Wang Y, Wluka AE, O’Sullivan R, Jones G, et al. 
Physical inactivity is associated with narrower lumbar intervertebral discs, 
high fat content of paraspinal muscles and low back pain and disability. 
Arthritis Res Ther (2015) 17:114. doi:10.1186/s13075-015-0629-y 
43. D’Hooge R, Cagnie B, Crombez G, Vanderstraeten G, Dolphens M, Danneels L. 
Increased intramuscular fatty infiltration without differences in lumbar 
muscle cross-sectional area during remission of unilateral recurrent low back 
pain. Man Ther (2012) 17(6):584–8. doi:10.1016/j.math.2012.06.007 
44. Mannion AF. Fibre type characteristics and function of the human para-
spinal muscles: normal values and changes in association with low back 
pain. J Electromyogr Kinesiol (1999) 9(6):363–77. doi:10.1016/S1050-6411 
(99)00010-3 
45. Mannion AF, Dumas GA, Stevenson JM, Cooper RG. The influence of muscle 
fiber size and type distribution on electromyographic measures of back 
muscle fatigability. Spine (Phila Pa 1976) (1998) 23(5):576–84. doi:10.1097/ 
00007632-199803010-00010 
46. Cho KH, Beom JW, Lee TS, Lim JH, Lee TH, Yuk JH. Trunk muscles 
strength as a risk factor for nonspecific low back pain: a pilot study. Ann 
Rehabil Med (2014) 38(2):234–40. doi:10.5535/arm.2014.38.2.234 
47. Payne N, Gledhill N, Katzmarzyk PT, Jamnik V. Health-related fitness, 
physical activity, and history of back pain. Can J Appl Physiol (2000) 25(4): 
236–49. doi:10.1139/h00-018 
48. Suehiro T, Mizutani M, Ishida H, Kobara K, Osaka H, Watanabe S. 
Individuals with chronic low back pain demonstrate delayed onset of the 
back muscle activity during prone hip extension. J Electromyogr Kinesiol 
(2015) 25(4):675–80. doi:10.1016/j.jelekin.2015.04.013 
49. Dankaerts W, O’Sullivan P, Burnett A, Straker L. Differences in sitting 
postures are associated with nonspecific chronic low back pain disorders 
when patients are subclassified. Spine (Phila Pa 1976) (2006) 31(6):698–704. 
doi:10.1097/01.brs.0000202532.76925.d2 
50. Teasell R, Dittmer DK. Complications of immobilization and bed rest. Part 2: 
other complications. Can Fam Physician (1993) 39:1440–2, 1445–6. 
7Valdivieso et al. Muscle Perfusion and CLBP
Frontiers in Medicine | www.frontiersin.org March 2018 | Volume 5 | Article 77
51. Dittmer DK, Teasell R. Complications of immobilization and bed rest. 
Part 1: musculoskeletal and cardiovascular complications. Can Fam Physician 
(1993) 39:1428–32, 1435–7. 
52. Gogia P, Schneider VS, LeBlanc AD, Krebs J, Kasson C, Pientok C. Bed rest 
effect on extremity muscle torque in healthy men. Arch Phys Med Rehabil 
(1988) 69(12):1030–2. 
53. Cassisi JE, Robinson ME, O’Conner P, MacMillan M. Trunk strength and 
lumbar paraspinal muscle activity during isometric exercise in chronic low-
back pain patients and controls. Spine (Phila Pa 1976) (1993) 18(2):245–51. 
doi:10.1097/00007632-199302000-00012 
54. Steele J, Bruce-Low S. Steiger et al. 2011: relationships and specificity in CLBP 
rehabilitation through exercise. Eur Spine J (2012) 21(9):1887; author reply 
8–9. doi:10.1007/s00586-012-2449-y 
55. Steele J, Bruce-Low S, Smith D. A review of the clinical value of isolated 
lumbar extension resistance training for chronic low back pain. PM R (2015) 
7(2):169–87. doi:10.1016/j.pmrj.2014.10.009 
56. Carpenter DM, Nelson BW. Low back strengthening for the prevention 
and treatment of low back pain. Med Sci Sports Exerc (1999) 31(1):18–24. 
doi:10.1097/00005768-199901000-00005 
57. Rainville J, Hartigan C, Martinez E, Limke J, Jouve C, Finno M. Exercise as a 
treatment for chronic low back pain. Spine J (2004) 4(1):106–15. doi:10.1016/
S1529-9430(03)00174-8 
58. Durmus D, Durmaz Y, Canturk F. Effects of therapeutic ultrasound and 
electrical stimulation program on pain, trunk muscle strength, disability, 
walking performance, quality of life, and depression in patients with low back 
pain: a randomized-controlled trial. Rheumatol Int (2010) 30(7):901–10. 
doi:10.1007/s00296-009-1072-7 
59. Rowell LB. Ideas about control of skeletal and cardiac muscle blood flow 
(1876–2003): cycles of revision and new vision. J Appl Physiol (1985) (2004) 
97(1):384–92. doi:10.1152/japplphysiol.01220.2003 
60. Joyner MJ, Casey DP. Regulation of increased blood flow (hyperemia) to 
muscles during exercise: a hierarchy of competing physiological needs. 
Physiol Rev (2015) 95(2):549–601. doi:10.1152/physrev.00035.2013 
61. Hellsten Y. Limitations of skeletal muscle oxygen supply in ageing. J Physiol 
(2016) 594(8):2259–60. doi:10.1113/JP272062 
62. Mense S. Muscle pain: mechanisms and clinical significance. Dtsch Arztebl 
Int (2008) 105(12):214–9. doi:10.3238/artzebl.2008.0214 
63. Snijders T, Nederveen JP, Joanisse S, Leenders M, Verdijk LB, van Loon LJ, 
et  al. Muscle fibre capillarization is a critical factor in muscle fibre 
hypertrophy during resistance exercise training in older men. J Cachexia 
Sarcopenia Muscle (2017) 8(2):267–76. doi:10.1002/jcsm.12137 
64. Vincent MA, Clerk LH, Rattigan S, Clark MG, Barrett EJ. Active role for the 
vasculature in the delivery of insulin to skeletal muscle. Clin Exp Pharmacol 
Physiol (2005) 32(4):302–7. doi:10.1111/j.1440-1681.2005.04188.x 
65. Dinenno FA, Seals DR, DeSouza CA, Tanaka H. Age-related decreases in 
basal limb blood flow in humans: time course, determinants and habitual 
exercise effects. J Physiol (2001) 531(Pt 2):573–9. doi:10.1111/j.1469- 
7793.2001.0573i.x 
66. Fluck M, Hoppeler H. Molecular basis of skeletal muscle plasticity – from gene 
to form and function. Rev Physiol Biochem Pharmacol (2003) 146:159–216. 
doi:10.1007/s10254-002-0004-7 
67. Kauppila LI. Atherosclerosis and disc degeneration/low-back pain – a sys-
tematic review. Eur J Vasc Endovasc Surg (2009) 37(6):661–70. doi:10.1016/j.
ejvs.2009.02.006 
68. Kurunlahti M, Karppinen J, Haapea M, Niinimaki J, Autio R, Vanharanta H, 
et  al. Three-year follow-up of lumbar artery occlusion with magnetic 
resonance angiography in patients with sciatica: associations between 
occlusion and patient-reported symptoms. Spine (Phila Pa 1976) (2004) 
29(16):1804–8; discussion 9. doi:10.1097/01.BRS.0000134576.77709.64 
69. Song J, Lee JB, Suh JK. Clinicopathological considerations in patients with 
lumbosacral extraforaminal stenosis. J Clin Neurosci (2009) 16(5):650–4. 
doi:10.1016/j.jocn.2008.06.003 
70. Liu JT, Liao WJ, Chang CS, Chen YH. Lower limb pain caused by insufficient 
muscular microcirculation. Indian J Surg (2014) 76(1):70–5. doi:10.1007/
s12262-012-0628-z 
71. Datta G, Gnanalingham KK, Peterson D, Mendoza N, O’Neill K, 
Van Dellen J, et  al. Back pain and disability after lumbar laminectomy: 
is there a relationship to muscle retraction? Neurosurgery (2004) 54(6): 
1413–20; discussion 20. doi:10.1227/01.NEU.0000124751.57121.A6 
72. Paryavi E, Jobin CM, Ludwig SC, Zahiri H, Cushman J. Acute exertional 
lumbar paraspinal compartment syndrome. Spine (Phila Pa 1976) (2010) 
35(25):E1529–33. doi:10.1097/BRS.0b013e3181ec4023 
73. Olivier N, Thevenon A, Berthoin S, Prieur F. An exercise therapy program 
can increase oxygenation and blood volume of the erector spinae muscle 
during exercise in chronic low back pain patients. Arch Phys Med Rehabil 
(2013) 94(3):536–42. doi:10.1016/j.apmr.2012.10.028 
74. Kell RT, Bhambhani Y. In vivo erector spinae muscle blood volume and 
oxygenation measures during repetitive incremental lifting and lowering 
in chronic low back pain participants. Spine (Phila Pa 1976) (2006) 
31(22):2630–7. doi:10.1097/01.brs.0000240647.57959.72 
75. Kovacs KM, Marras WS, Litsky AS, Gupta P, Ferguson SA. Localized oxy-
gen use of healthy and low back pain individuals during controlled trunk 
movements. J Spinal Disord (2001) 14(2):150–8. doi:10.1097/00002517- 
200104000-00010 
76. Olfert IM, Baum O, Hellsten Y, Egginton S. Advances and challenges 
in skeletal muscle angiogenesis. Am J Physiol Heart Circ Physiol (2016) 
310(3):H326–36. doi:10.1152/ajpheart.00635.2015 
77. Dapp C, Schmutz S, Hoppeler H, Fluck M. Transcriptional reprogramming 
and ultrastructure during atrophy and recovery of mouse soleus muscle. 
Physiol Genomics (2004) 20(1):97–107. doi:10.1152/physiolgenomics. 
00100.2004 
78. Fraser GM, Morton JS, Schmidt SM, Bourque S, Davidge ST, Davenport MH, 
et  al. Reduced uterine perfusion pressure decreases functional capillary 
density in skeletal muscle. Am J Physiol Heart Circ Physiol (2015) 309(12): 
H2002–7. doi:10.1152/ajpheart.00641.2015 
79. Pelletier-Fleury N, Lanoe JL, Fleury B, Fardeau M. The cost of treating COPD 
patients with long-term oxygen therapy in a French population. Chest (1996) 
110(2):411–6. doi:10.1378/chest.110.2.411 
80. Hudlicka O. Development and adaptability of microvasculature in skeletal 
muscle. J Exp Biol (1985) 115:215–28. 
81. Korthuis RJ. Skeletal Muscle Circulation. San Rafael, CA: Integrated Systems 
Physiology: From Molecule to Function to Disease (2011).
82. Giombini A, Giovannini V, Di Cesare A, Pacetti P, Ichinoseki-Sekine N, 
Shiraishi M, et  al. Hyperthermia induced by microwave diathermy in the 
management of muscle and tendon injuries. Br Med Bull (2007) 83:379–96. 
doi:10.1093/bmb/ldm020 
83. Hudlicka O. Growth of capillaries in skeletal and cardiac muscle. Circ Res 
(1982) 50(4):451–61. doi:10.1161/01.RES.50.4.451 
84. Hudlicka O. What makes blood vessels grow? J Physiol (1991) 444:1–24. 
doi:10.1113/jphysiol.1991.sp018863 
85. Hudlicka O, Price S. The role of blood flow and/or muscle hypoxia in 
capillary growth in chronically stimulated fast muscles. Pflugers Arch (1990) 
417(1):67–72. doi:10.1007/BF00370770 
86. Egginton S, Hudlicka O. Early changes in performance, blood flow and 
capillary fine structure in rat fast muscles induced by electrical stimulation. 
J Physiol (1999) 515(Pt 1):265–75. doi:10.1111/j.1469-7793.1999.265ad.x 
87. Sottile J. Regulation of angiogenesis by extracellular matrix. Biochim Biophys 
Acta (2004) 1654(1):13–22. doi:10.1016/j.bbcan.2003.07.002 
88. Dzau VJ, Gibbons GH. Endothelium and growth factors in vascular 
remodeling of hypertension. Hypertension (1991) 18(5 Suppl):III115–21. 
doi:10.1161/01.HYP.18.5_Suppl.III115 
89. Rogers MS, D’Amato RJ. Common polymorphisms in angiogenesis. Cold 
Spring Harb Perspect Med (2012) 2(11):a006510. doi:10.1101/cshperspect.
a006510 
90. van Ginkel S, Ruoss S, Valdivieso P, Degens H, Waldron S, de Haan A, et al. 
ACE inhibition modifies exercise-induced pro-angiogenic and mitochondrial 
gene transcript expression. Scand J Med Sci Sports (2016) 26(10):1180–7. 
doi:10.1111/sms.12572 
91. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass S, 
et  al. Expression of tenascin by vascular smooth muscle cells. Alterations 
in hypertensive rats and stimulation by angiotensin II. Am J Pathol (1992) 
141(2):377–88. 
92. Gorman JL, Liu ST, Slopack D, Shariati K, Hasanee A, Olenich S, et  al. 
Angiotensin II evokes angiogenic signals within skeletal muscle through 
co-ordinated effects on skeletal myocytes and endothelial cells. PLoS One 
(2014) 9(1):e85537. doi:10.1371/journal.pone.0085537 
93. Greene AS. Life and death in the microcirculation: a role for angiotensin II. 
Microcirculation (1998) 5(2–3):101–7. doi:10.1038/sj.mn.7300024 
8Valdivieso et al. Muscle Perfusion and CLBP
Frontiers in Medicine | www.frontiersin.org March 2018 | Volume 5 | Article 77
94. Hahn AW, Kern F, Jonas U, John M, Buhler FR, Resink TJ. Functional 
aspects of vascular tenascin-C expression. J Vasc Res (1995) 32(3):162–74. 
doi:10.1159/000159090 
95. Mustafa DA, Dekker LJ, Stingl C, Kremer A, Stoop M, Sillevis Smitt PA, 
et  al. A proteome comparison between physiological angiogenesis and 
angiogenesis in glioblastoma. Mol Cell Proteomics (2012) 11(6):M111008466. 
doi:10.1074/mcp.M111.008466 
96. Vaughan D, Huber-Abel FA, Graber F, Hoppeler H, Fluck M. The angio-
tensin converting enzyme insertion/deletion polymorphism alters the 
response of muscle energy supply lines to exercise. Eur J Appl Physiol (2013) 
113(7):1719–29. doi:10.1007/s00421-012-2583-6 
97. Valdivieso P, Vaughan D, Laczko E, Brogioli M, Waldron S, Rittweger J, et al. 
The metabolic response of skeletal muscle to endurance exercise is modified 
by the ACE-I/D gene polymorphism and training state. Front Physiol (2017) 
8:993. doi:10.3389/fphys.2017.00993 
98. Valdivieso P, Toigo M, Hoppeler H, Fluck M. T/T homozygosity of the tenascin-C 
gene polymorphism rs2104772 negatively influences exercise-induced angiogene-
sis. PLoS One (2017) 12(4):e0174864. doi:10.1371/journal.pone.0174864 
99. Saunders CJ, van der Merwe L, Posthumus M, Cook J, Handley CJ, Collins M, 
et  al. Investigation of variants within the COL27A1 and TNC genes and 
Achilles tendinopathy in two populations. J Orthop Res (2013) 31(4):632–7. 
doi:10.1002/jor.22278 
100. Matsuda A, Hirota T, Akahoshi M, Shimizu M, Tamari M, Miyatake A, et al. 
Coding SNP in tenascin-C Fn-III-D domain associates with adult asthma. 
Hum Mol Genet (2005) 14(19):2779–86. doi:10.1093/hmg/ddi311 
101. Campbell DJ. Angiotensin converting enzyme (ACE) inhibitors and kinin 
metabolism: evidence that ACE inhibitors may inhibit a kininase other 
than ACE. Clin Exp Pharmacol Physiol (1995) 22(12):903–11. doi:10.1111/j. 
1440-1681.1995.tb02325.x 
102. Steckelings UM, Artuc M, Wollschlager T, Wiehstutz S, Henz BM. Angiotensin-
converting enzyme inhibitors as inducers of adverse cutaneous reactions. 
Acta Derm Venereol (2001) 81(5):321–5. doi:10.1080/000155501317140007 
103. Lin CC, Chen WN, Chen CJ, Lin YW, Zimmer A, Chen CC. An antinocicep-
tive role for substance P in acid-induced chronic muscle pain. Proc Natl Acad 
Sci U S A (2012) 109(2):E76–83. doi:10.1073/pnas.1108903108 
104. Pollak KA, Swenson JD, Vanhaitsma TA, Hughen RW, Jo D, White AT, et al. 
Exogenously applied muscle metabolites synergistically evoke sensations of 
muscle fatigue and pain in human subjects. Exp Physiol (2014) 99(2):368–80. 
doi:10.1113/expphysiol.2013.075812 
105. Sun WH, Chen CC. Roles of proton-sensing receptors in the transition 
from acute to chronic pain. J Dent Res (2016) 95(2):135–42. doi:10.1177/ 
0022034515618382 
106. Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia 
and other musculoskeletal disorders. Curr Pain Headache Rep (2003) 
7(5):355–61. doi:10.1007/s11916-003-0034-0 
107. Muller-Schwefe G, Morlion B, Ahlbeck K, Alon E, Coaccioli S, Coluzzi F, 
et al. Treatment for chronic low back pain: the focus should change to multi-
modal management that reflects the underlying pain mechanisms. Curr 
Med Res Opin (2017) 33(7):1199–210. doi:10.1080/03007995.2017. 
1298521 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
The reviewer LT and the handling editor declared their shared affiliation.
Copyright © 2018 Valdivieso, Franchi, Gerber and Flück. This is an open-access 
article distributed under the terms of the Creative Commons Attribution License 
(CC BY). The use, distribution or reproduction in other forums is permitted, 
provided the original author(s) and the copyright owner are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 
practice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
